Last reviewed · How we verify
IDp-120 Vehicle Gel
IDp-120 Vehicle Gel is a Small molecule drug developed by Bausch Health Americas, Inc.. It is currently in Phase 3 development for Dermatological conditions (specific indication under investigation in Phase 3).
IDp-120 is a topical immunomodulatory gel formulation designed to enhance local immune response at the application site.
IDp-120 is a topical immunomodulatory gel formulation designed to enhance local immune response at the application site. Used for Dermatological conditions (specific indication under investigation in Phase 3).
At a glance
| Generic name | IDp-120 Vehicle Gel |
|---|---|
| Sponsor | Bausch Health Americas, Inc. |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
IDp-120 Vehicle Gel is a topical formulation intended to deliver immunomodulatory activity through a gel vehicle. The exact molecular mechanism and active pharmaceutical ingredient are not publicly disclosed in detail, but the product is being developed for dermatological indications where local immune stimulation may provide therapeutic benefit.
Approved indications
- Dermatological conditions (specific indication under investigation in Phase 3)
Common side effects
Key clinical trials
- Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris (PHASE3)
- Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris (PHASE3)
- Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (PHASE2)
- A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IDp-120 Vehicle Gel CI brief — competitive landscape report
- IDp-120 Vehicle Gel updates RSS · CI watch RSS
- Bausch Health Americas, Inc. portfolio CI
Frequently asked questions about IDp-120 Vehicle Gel
What is IDp-120 Vehicle Gel?
How does IDp-120 Vehicle Gel work?
What is IDp-120 Vehicle Gel used for?
Who makes IDp-120 Vehicle Gel?
What development phase is IDp-120 Vehicle Gel in?
Related
- Manufacturer: Bausch Health Americas, Inc. — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Dermatological conditions (specific indication under investigation in Phase 3)